Pages that link to "Q45307205"

The following pages link to 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein (Q45307205):

Displaying 28 items.

• Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis (Q24297593) (← links)
• The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity (Q24298721) (← links)
• N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice (Q27306025) (← links)
• 14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes (Q27930016) (← links)
• BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells (Q28251851) (← links)
• Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors (Q28472246) (← links)
• Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity (Q33459255) (← links)
• Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice (Q33594383) (← links)
• Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments (Q34117333) (← links)
• Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease (Q34163054) (← links)
• Network organization of the huntingtin proteomic interactome in mammalian brain (Q34287971) (← links)
• NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases (Q35042712) (← links)
• Identification of a novel ATPase activity in 14-3-3 proteins--evidence from enzyme kinetics, structure guided modeling and mutagenesis studies. (Q35051866) (← links)
• Functional EF-hands in neuronal calcium sensor GCAP2 determine its phosphorylation state and subcellular distribution in vivo, and are essential for photoreceptor cell integrity (Q35212375) (← links)
• Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis (Q37165188) (← links)
• Developing intrabodies for the therapeutic suppression of neurodegenerative pathology (Q37571975) (← links)
• 14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology (Q37692247) (← links)
• Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins (Q37961564) (← links)
• Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience (Q38016600) (← links)
• Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration (Q38108756) (← links)
• Neuroprotective function of 14-3-3 proteins in neurodegeneration (Q38173380) (← links)
• 14-3-3 and aggresome formation: implications in neurodegenerative diseases (Q38189235) (← links)
• Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology (Q38684995) (← links)
• Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins. (Q39038460) (← links)
• Monomeric 14-3-3ζ has a chaperone-like activity and is stabilized by phosphorylated HspB6. (Q41824229) (← links)
• NMR spectroscopy of 14-3-3ζ reveals a flexible C-terminal extension: differentiation of the chaperone and phosphoserine-binding activities of 14-3-3ζ. (Q43693240) (← links)
• 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature (Q47134911) (← links)
• Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells (Q90580774) (← links)